• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物诱导和辐射诱导的DNA链断裂激活DNA依赖性蛋白激酶。

Activation of the DNA-dependent protein kinase by drug-induced and radiation-induced DNA strand breaks.

作者信息

Mårtensson Susanne, Nygren Jonas, Osheroff Neil, Hammarsten Ola

机构信息

Clinical Chemistry, Gothenburg University, Sahlgrenska University Hospital, 41345 Gothenburg, Sweden.

出版信息

Radiat Res. 2003 Sep;160(3):291-301. doi: 10.1667/0033-7587(2003)160[0291:aotdpk]2.0.co;2.

DOI:10.1667/0033-7587(2003)160[0291:aotdpk]2.0.co;2
PMID:12926987
Abstract

The DNA-dependent protein kinase (DNA-PK) is a DNA-end activated protein kinase that is required for efficient repair of DNA double-strand breaks (DSBs) and for normal resistance to ionizing radiation. DNA-PK is composed of a DNA-binding subunit, Ku, and a catalytic subunit, DNA-PKcs (PRKDC). We have previously shown that PRKDC is activated when the enzyme interacts with the terminal nucleotides of a DSB. These nucleotides are often damaged when DSBs are introduced by anticancer agents and could therefore prevent recognition by DNA-PK. To determine whether DNA-PK could recognize DNA strand breaks generated by agents used in the treatment of cancer, we damaged plasmid DNA with anticancer drugs and ionizing radiation. The DNA breaks were tested for the ability to activate purified DNA-PK. The data indicate that DSBs produced by bleomycin, calicheamicin and two types of ionizing radiation ((137)Cs gamma rays and N(7+) ions: high and low linear energy transfer, respectively) activate DNA-PK to levels matching the kinase activation obtained with simple restriction endonuclease-induced DSBs. In contrast, the protein-linked DSBs produced by etoposide and topoisomerase II failed to bind and activate DNA-PK. Our findings indicate that DNA-PK recognizes DSBs regardless of chemical complexity but cannot recognize the protein-linked DSBs produced by etoposide and topoisomerase II.

摘要

DNA依赖性蛋白激酶(DNA-PK)是一种DNA末端激活的蛋白激酶,对于DNA双链断裂(DSB)的有效修复以及对电离辐射的正常抗性是必需的。DNA-PK由一个DNA结合亚基Ku和一个催化亚基DNA-PKcs(PRKDC)组成。我们之前已经表明,当该酶与DSB的末端核苷酸相互作用时,PRKDC会被激活。当抗癌药物引入DSB时,这些核苷酸常常会受损,因此可能会阻止DNA-PK的识别。为了确定DNA-PK是否能够识别癌症治疗中使用的药物所产生的DNA链断裂,我们用抗癌药物和电离辐射损伤了质粒DNA。测试了DNA断裂激活纯化的DNA-PK的能力。数据表明,博来霉素、加利车霉素以及两种类型的电离辐射((137)Csγ射线和N(7+)离子:分别为高和低传能线密度)产生的DSB将DNA-PK激活到与简单限制性内切酶诱导的DSB所获得的激酶激活水平相匹配的程度。相比之下,依托泊苷和拓扑异构酶II产生的蛋白质连接的DSB未能结合并激活DNA-PK。我们的研究结果表明,DNA-PK能够识别DSB,而不论其化学复杂性如何,但不能识别依托泊苷和拓扑异构酶II产生的蛋白质连接的DSB。

相似文献

1
Activation of the DNA-dependent protein kinase by drug-induced and radiation-induced DNA strand breaks.药物诱导和辐射诱导的DNA链断裂激活DNA依赖性蛋白激酶。
Radiat Res. 2003 Sep;160(3):291-301. doi: 10.1667/0033-7587(2003)160[0291:aotdpk]2.0.co;2.
2
Differential etoposide sensitivity of cells deficient in the Ku and DNA-PKcs components of the DNA-dependent protein kinase.DNA依赖性蛋白激酶的Ku和DNA-PKcs成分缺陷的细胞对依托泊苷的敏感性差异
Carcinogenesis. 1998 Jun;19(6):965-71. doi: 10.1093/carcin/19.6.965.
3
The DNA-dependent protein kinase interacts with DNA to form a protein-DNA complex that is disrupted by phosphorylation.DNA依赖性蛋白激酶与DNA相互作用形成一种蛋白质-DNA复合物,该复合物会因磷酸化作用而被破坏。
Biochemistry. 2002 Oct 22;41(42):12706-14. doi: 10.1021/bi0263558.
4
Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks.DNA双链断裂重新连接需要DNA依赖性蛋白激酶催化亚基的自磷酸化。
Genes Dev. 2002 Sep 15;16(18):2333-8. doi: 10.1101/gad.1015202.
5
Mechanisms of DNA double strand break repair and chromosome aberration formation.DNA双链断裂修复及染色体畸变形成的机制。
Cytogenet Genome Res. 2004;104(1-4):14-20. doi: 10.1159/000077461.
6
The activity of the DNA-dependent protein kinase (DNA-PK) complex is determinant in the cellular response to nitrogen mustards.DNA依赖性蛋白激酶(DNA-PK)复合物的活性在细胞对氮芥的反应中起决定性作用。
Biochimie. 2000 Jan;82(1):25-8. doi: 10.1016/s0300-9084(00)00341-2.
7
Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase.人类Ku自身抗原可结合顺铂损伤的DNA,但无法刺激人类DNA激活的蛋白激酶。
J Biol Chem. 1996 Jun 7;271(23):13861-7. doi: 10.1074/jbc.271.23.13861.
8
Mouse but not human embryonic stem cells are deficient in rejoining of ionizing radiation-induced DNA double-strand breaks.小鼠而非人类胚胎干细胞在电离辐射诱导的DNA双链断裂修复方面存在缺陷。
DNA Repair (Amst). 2008 Sep 1;7(9):1471-83. doi: 10.1016/j.dnarep.2008.05.005. Epub 2008 Jul 3.
9
Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.顺铂 - DNA加合物抑制DNA依赖蛋白激酶(DNA-PK)的Ku亚基的易位。
Nucleic Acids Res. 2000 Dec 1;28(23):4634-41. doi: 10.1093/nar/28.23.4634.
10
Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions.Ku70介导的双链断裂修复需要与Ku80异源二聚化并具备DNA结合功能。
EMBO J. 1997 Nov 17;16(22):6874-85. doi: 10.1093/emboj/16.22.6874.

引用本文的文献

1
DNA-PK and ATM drive phosphorylation signatures that antagonistically regulate cytokine responses to herpesvirus infection or DNA damage.DNA-PK 和 ATM 驱动磷酸化特征,拮抗调节细胞因子对疱疹病毒感染或 DNA 损伤的反应。
Cell Syst. 2024 Apr 17;15(4):339-361.e8. doi: 10.1016/j.cels.2024.03.003. Epub 2024 Apr 8.
2
DNA fragility at the / locus: insights from old and new technologies./ 位点的 DNA 脆弱性:新旧技术的启示。
Open Biol. 2023 Jan;13(1):220232. doi: 10.1098/rsob.220232. Epub 2023 Jan 11.
3
Therapeutic Targeting of Acute Myeloid Leukemia by Gemtuzumab Ozogamicin.
吉妥珠单抗奥唑米星对急性髓系白血病的治疗靶向作用
Cancers (Basel). 2021 Sep 11;13(18):4566. doi: 10.3390/cancers13184566.
4
A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes.VCP/p97 在药物稳定的拓扑异构酶 II-DNA 共价复合物加工中的作用。
Mol Pharmacol. 2021 Jul;100(1):57-62. doi: 10.1124/molpharm.121.000262. Epub 2021 May 3.
5
Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment.急性髓系白血病治疗中吉妥珠单抗奥佐米星反应的生物标志物。
Int J Mol Sci. 2020 Aug 6;21(16):5626. doi: 10.3390/ijms21165626.
6
Small Molecule Inhibitors Confirm Ubiquitin-Dependent Removal of TOP2-DNA Covalent Complexes.小分子抑制剂证实泛素依赖性去除拓扑异构酶 II-DNA 共价复合物。
Mol Pharmacol. 2020 Sep;98(3):222-233. doi: 10.1124/mol.119.118893. Epub 2020 Jun 25.
7
DNA-PK Inhibitor, M3814, as a New Combination Partner of Mylotarg in the Treatment of Acute Myeloid Leukemia.DNA依赖蛋白激酶抑制剂M3814作为麦罗塔治疗急性髓系白血病的新型联合用药伙伴
Front Oncol. 2020 Feb 13;10:127. doi: 10.3389/fonc.2020.00127. eCollection 2020.
8
Suppressing proteasome mediated processing of topoisomerase II DNA-protein complexes preserves genome integrity.抑制蛋白酶体介导的拓扑异构酶 II-DNA 蛋白复合物的加工可保持基因组完整性。
Elife. 2020 Feb 14;9:e53447. doi: 10.7554/eLife.53447.
9
The Deubiquitinating Enzyme Inhibitor PR-619 is a Potent DNA Topoisomerase II Poison.去泛素化酶抑制剂 PR-619 是一种有效的 DNA 拓扑异构酶 II 抑制剂。
Mol Pharmacol. 2019 Nov;96(5):562-572. doi: 10.1124/mol.119.117390. Epub 2019 Sep 12.
10
Effect of TDP2 on the Level of TOP2-DNA Complexes and SUMOylated TOP2-DNA Complexes.TDP2 对 TOP2-DNA 复合物和 SUMOylated TOP2-DNA 复合物水平的影响。
Int J Mol Sci. 2018 Jul 14;19(7):2056. doi: 10.3390/ijms19072056.